These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21565990)

  • 1. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.
    Call JA; Ervasti JM; Lowe DA
    J Appl Physiol (1985); 2011 Jul; 111(1):200-5. PubMed ID: 21565990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional substitution by TAT-utrophin in dystrophin-deficient mice.
    Sonnemann KJ; Heun-Johnson H; Turner AJ; Baltgalvis KA; Lowe DA; Ervasti JM
    PLoS Med; 2009 May; 6(5):e1000083. PubMed ID: 19478831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.
    Zhou L; Rafael-Fortney JA; Huang P; Zhao XS; Cheng G; Zhou X; Kaminski HJ; Liu L; Ransohoff RM
    J Neurol Sci; 2008 Jan; 264(1-2):106-11. PubMed ID: 17889902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of proteases in excitation-contraction coupling failure in muscular dystrophy.
    Mázala DA; Grange RW; Chin ER
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C33-40. PubMed ID: 25298424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
    van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
    FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
    Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
    J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
    Albesa M; Ogrodnik J; Rougier JS; Abriel H
    Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
    van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
    Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
    Wang B; Li J; Fu FH; Xiao X
    J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
    Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
    Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
    Capogrosso RF; Mantuano P; Uaesoontrachoon K; Cozzoli A; Giustino A; Dow T; Srinivassane S; Filipovic M; Bell C; Vandermeulen J; Massari AM; De Bellis M; Conte E; Pierno S; Camerino GM; Liantonio A; Nagaraju K; De Luca A
    FASEB J; 2018 Feb; 32(2):1025-1043. PubMed ID: 29097503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice.
    Strimpakos G; Corbi N; Pisani C; Di Certo MG; Onori A; Luvisetto S; Severini C; Gabanella F; Monaco L; Mattei E; Passananti C
    J Cell Physiol; 2014 Sep; 229(9):1283-91. PubMed ID: 24469912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.
    Lindsay A; Southern WM; McCourt PM; Larson AA; Hodges JS; Lowe DA; Ervasti JM
    FEBS J; 2019 Jul; 286(13):2562-2576. PubMed ID: 30942954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophin deficiency disrupts muscle clock expression and mitochondrial quality control in
    Hardee JP; Caldow MK; Chan ASM; Plenderleith SK; Trieu J; Koopman R; Lynch GS
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C288-C296. PubMed ID: 34191629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy.
    Berry SE; Liu J; Chaney EJ; Kaufman SJ
    Regen Med; 2007 May; 2(3):275-88. PubMed ID: 17511564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.